🔗 Permalink

Inventor profile of:

Luke O'neill

City:

Dublin

Country:

Ireland

Published Applications:

Last publication date:

2025-01-16

Top Assignees for applications by Luke O'neill

The entities that hold a legal rights for patent applications filed by inventor O'neill Luke:

The University of Queensland 5 Queensland, Australia
THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN 5 Dublin, Ireland
OPSONA Therapeutics Ltd 4 Dublin, Ireland
Opsona Therapeutics Ltd 3 Dublin 8, Ireland
OPSONA THERAPEUTICS LIMITED 1 Dublin, Ireland
The Provost ,Fellows and Scholars oftheCollegeof theHolyandUndividedTrinityof Queen ElizabethNearDu 1 Dublin 2, Ireland
The Provost, Fellows, Foundation Scholars, And The Other Members Of Board, Of The College Of The Hol 1 Dublin 2, Ireland
THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, AND THE AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN 1 Dublin, Ireland

Recent patent applications by O'neill Luke

Luke O'neill from Dublin, IE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-01-16

US20250018019A1

Human necessities

TREATMENT OF INTERFERON DRIVEN INFLAMMATION

#2 | 2022-04-14

US20220112159A1

Chemistry; metallurgy

Sulfonylureas and related compounds and use of same

#3 | 2020-09-24

US20200299284A1

Chemistry; metallurgy

Sulfonylureas and related compounds and use of same

#4 | 2020-07-02

US20200207780A1

Chemistry; metallurgy

Compounds and uses

#5 | 2019-11-28

US20190359564A1

Chemistry; metallurgy

Sulfonylureas and related compounds and use of same

#6 | 2019-10-17

US20190314454A1

Human necessities

Composition and methods for the treatment of degenerative retinal conditions

#7 | 2018-02-15

US20180044287A1

Chemistry; metallurgy

Sulfonylureas and related compounds and use of same

#8 | 2014-08-21

US20140234252A1

Human necessities

Composition and Methods for the Treatment of Degenerative Retinal Conditions

#9 | 2012-10-11

US20120258103A1

Chemistry; metallurgy

Treatment of renal disease

#10 | 2012-06-07

US20120141466A9

Human necessities

Composition and method for treatment of reperfusion injury and tissue damage

#11 | 2011-12-01

US20110293601A1

Human necessities

COMPOSITION AND METHOD FOR TREATMENT OF REPERFUSION INJURY AND TISSUE DAMAGE

#12 | 2010-12-30

US20100330067A1

Chemistry; metallurgy

Methods for suppressing Toll-like Receptor 4 (TLR4) function using TLR14 antagonists

#13 | 2010-11-04

US20100278817A1

Chemistry; metallurgy

COMPOUNDS AND METHODS FOR THE TREATMENT OF RENAL DISEASE

#14 | 2010-09-30

US20100247527A1

Chemistry; metallurgy

Method for the treatment of rheumatoid arthritis using a TLR2 antagonistic antibody

InventorID:

879053 ⎘